OPEN END-TURBO-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 02:02:25 2024-06-25 EDT | ||
| 14.88 EUR | +1.09% |
|
| Current month | +9.04% | ||
| 1 month | +6.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-25 | 14.88 | +1.09% |
| 24-06-24 | 14.72 | +3.81% |
| 24-06-21 | 14.18 | +0.42% |
| 24-06-20 | 14.12 | +2.24% |
| 24-06-19 | 13.81 | +0.58% |
Real-time BOERSE MUENCHEN
Last update June 25, 2024 at 02:02 am
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | TR9YZ5 |
| ISIN | DE000TR9YZ50 |
| Date issued | 2019-12-20 |
| Strike | 158.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8.95 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.88 € |
|---|---|
| Lowest since issue | 3.42 € |
| Spread | 0.42 € |
| Spread % | 2.74% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
318.2
USD
Average target price
316.4
USD
Spread / Average Target
-0.54%
- Stock Market
- Certificates
- Certificat
